Ischemic type biliary lesions in histidine-tryptophan-ketoglutarate (HTK) preserved liver grafts

International Journal of Artificial Organs

Volumn 29, Issue 3, 2006, Pages 329-334

  Moench, Christian ^a   Otto, G ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Bile duct damage; HTK solution; Liver transplantation; Low viscosity; Preservation

Indexed keywords

VISCOSITY;

ARTERIAL VESSELS; BILE DUCT DAMAGE; BILE DUCTS; BILIARY TREE; HISTIDINE-TRYPTOPHAN-KETOGLUTARATE-SOLUTION; KETOGLUTARATE; LIVER TRANSPLANTATION; LOW VISCOSITY; ORTHOTOPIC LIVER TRANSPLANTATION; PRESERVATION;

AMINO ACIDS;

AZATHIOPRINE; CYCLOSPORIN A; GLUTARIC ACID DERIVATIVE; HISTIDINE; STEROID; TACROLIMUS; TRYPTOPHAN;

ADULT; AGE; ALCOHOL LIVER CIRRHOSIS; AMYLOIDOSIS; ARTICLE; BILIARY TRACT DISEASE; CONTROLLED STUDY; DONOR; GRAFT DYSFUNCTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FAILURE; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PERFUSION; RECIPIENT; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT INDICATION; VIRUS HEPATITIS; VISCOSITY;

EID: 33744788100     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880602900311     Document Type: Article

References (20)

1. Theilmann L, Kuppers B, Kadmon M, et al. Biliary tract strictures after orthotopic liver transplantation: Diagnosis and management. Endoscopy 1994; 26: 517-22.
2. Sanchez-Urdazpal L, Gores G, Ward E, et al. Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology 1992; 16: 49-53.
3. Starzl T, Putnam C, Hansbrough J, Porter K, Reid H. Biliary complications after liver transplantation: With special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery 1977; 81: 212-21.
4. Iwatsuki S, Shaw Bj, Starzl T. Biliary tract complications in liver transplantation under cyclosporine-steroid therapy. Transplant Proc 1983; 15: 1288-9.
5. McMaster P, Herbertson B, Cusick C, Calne R, Williams R. Biliary sludging following liver transplantation in man. Transplantation 1978; 25: 56-62.
6. Sanchez-Urdazpal L, Gores G, Ward E, et al. Diagnostic features and clinical outcome of ischemic-type-biliary complications after orthotopic liver transplantation. Hepatology 1993; 17: 605-9.
7. Li S, Stratta R, Langnas A, Wood R, Marujo W, Shaw Bj. Diffuse biliary tract injury after orthotopic liver transplantation. Am J Surg 1992; 164: 536-40.
8. Kadmon M, Bleyl J, Küppers B, Otto G, Herfarth C. Biliary complications after prolonged UW-preservation of liver allografts. Transplant Proc 1993; 25: 1288-9.
9. Langrehr J, Schneller A, Neuhaus R, Vogl T, Hintze R, Neuhaus P. Etiologic factors and incidence of ischemic type biliary lesions (ITBL) after liver transplantation. Langenbecks Arch Chir Suppl Kongressbd 1998; 115: 1560-2.
10. Moench C, Moench K, Lohse A, Thies J, Otto G. Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion. Liver Transpl 2003; 9: 285-9.
11. Gubernatis G. Technique of organ procurement and preservation of liver and pancreas. Baillieres Clin Gastroenterol 1989; 3: 799-811.
12. Starzl TE, Hakala TR, Shaw BW Jr, et al. A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet 1984; 158: 223-30.
13. Gugenheim J, Samuel D, Reynes M, Bismuth H. Liver transplantation across ABO blood group barriers. Lancet 1990; 336: 519-23.
14. Zajko A, Campbell W, Logsdon G, et al. Cholangiographic findings in hepatic artery occlusion after liver transplantation. AJR Am J Roentgenol 1987; 149: 485-9.
15. Moench C, Uhrig A, Lohse A, Otto G. CC chemokine receptor 5Delta32 polymorphism - a risk factor for ischemic-type biliary lesions following orthotopic liver transplantation. Liver Transpl 2004; 10: 434-9.
16. Golling M, Zipperle S, Weimer R, et al. Chronic liver immunologic factors in ischemic type biliary lesions (ITBL) - reduced Th1 and increased Th2 response. Langenbecks Arch Chir Suppl Kongressbd 1998; 115: 1557-9.
17. Gubermatis G, Pichimayr R, Lamesch P, et al. HTK-solution (Bretschneider) for human liver transplantation. First clinical experiences. Langenbecks Arch Chir 1990; 375: 66-70.
18. Erhard J, Lange R, Scherer R, et al. Comparison of histidine-tryptophan-ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation. A prospective randomized trial. Transpl Int 1994; 7:177-81.
19. Canelo R, Hakim N, Ringe B. Experience with histidine tryptophan ketoglutarate versus University of Wisconsin preservation solutions in transplantation. Int Surg 2003; 88: 145-51.
20. Pokorny H, Rasoul-Rockenschaub S, Langer F, et al. Histidine-tryptophan-ketoglutarate solution for organ preservation in human liver transplantation - a prospective multi-center observation study. Transpl Int 2004; 17: 256-60.